“MEDISCIS executes trials from FIM to POC in which safety, tolerability, pharmacokinetics, and pharmacodynamics of compounds are evaluated in healthy volunteers, patients, and in specific population subgroups.

All studies are conducted in accordance with governing ICH-GCP guidelines.

We offer a 54 bed capacity across 2 European clinical units. A medical staff of 5 Clinical Investigators ensures the highest level of physician attention.

Types of Studies

Safety and Tolerability (FIM, Combined SAD and MAD)
Pharmacokinetics (including complex interaction trials)
Pharmacodynamics (including Proof of Concept, QT prolongation, PFTs)

Population Groups

• Healthy (young and elderly)
• Asthma, COPD
• Allergic Rhinitis
• RA, Psoriasis, Eczema
• Hypertensive patients
• Dyslipidemic patients
• Type I and II diabetics
• Postmenopausal women
• Osteoporotic patients
• Parkinsonian patients
• GORD patients...

Pharmaco-Dynamic Tests and Advanced Equipment

• Cardio-pulmonary exercise tests
• Spirometry
• Diffusion capacity to CO
• Rhinomanometry
• Prick tests
• Planimetry (Wheel and Flare tests)
• Full Body Plethysmography
• Holters ECGs
• Ambulatory BP monitoring
• Continuous cardiac monitoring
• Platelet Aggregation / Coagulation Tests
• Glycemic clamp test
• PBMC Isolation
• Feces Sample Treatment
• Pupillometry
• Saccadic Eye Movements
• Vigilance and Cognitive tests
• Qualitative and Quantitative EEGs
• Challenge tests (Methacholine, AMP, Histamine, Sputum Induction)